Posted by Michael Wonder on 30 May 2019
HIV prevention pill to get insurance benefit in Korea
30 May 2019 - The local medical community is likely to use a drug to prevent HIV infection in earnest.
The government has decided to allow reimbursement for Gilead’s Truvada (tenofovir disoproxil fumarate/emtricitabine) for pre-exposure prophylaxis (PrEP).
The Ministry of Health and Welfare on Tuesday said it would grant insurance benefit for Truvada HIV-1 PrEP used for people who are negative in HIV-1 infection but at high risk due to sex with an HIV-positive partner, starting from June 7.
